Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide

• मुख्य लेखकों: Karen Schneck (लेखक), Shweta Urva (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2024-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Tirzepatide is a first‐in‐class glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist approved as for the treatment of type 2 diabetes mellitus. A population‐based pharmacokinetic (PK) model was developed from 19 pooled studies. Tirzepatide pharmacokineti...